- Home
- DXR vs RSF Comparison
DXR vs RSF Comparison
Compare DXR & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$9.26
Company Overview
Basic Information| Metric | DXR | RSF |
|---|---|---|
| Founded | 1970 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 59.0M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | DXR | RSF |
|---|---|---|
| Price | $9.26 | $14.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.2K | ★ 9.6K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $1,446,345.00 | N/A |
| Revenue This Year | $44,935.22 | N/A |
| Revenue Next Year | $74.79 | N/A |
| P/E Ratio | $33.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.45 | $14.23 |
| 52 Week High | $14.76 | $15.07 |
Technical Indicators
Market Signals| Indicator | DXR | RSF |
|---|---|---|
| Relative Strength Index (RSI) | 38.42 | 56.52 |
| Support Level | $9.21 | $14.61 |
| Resistance Level | $11.40 | $14.70 |
| Average True Range (ATR) | 0.68 | 0.07 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 0.00 | 61.11 |
Price Performance
Historical Comparison DXR
RSF
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.